Related Experiment Video
Updated: Jul 12, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
A novel protein B2URF3 from Akkermansia muciniphila increased by intermittent fasting alleviates vascular
Shi-Yu Zeng1,2, Jiang-Hua Liu3, Ying-Ying Xiang1
1Department of Metabolism and Endocrinology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
Abstract:
Vascular calcification (VC) is a major contributor to cardiovascular morbidity and mortality, yet effective therapies are lacking. Here, we show that alternate-day intermittent fasting (IF1:1) attenuates vitamin D-induced VC in mice, whereas a 5:2 regimen is ineffective. The protective effect of IF1:1 is gut microbiota-dependent, particularly through enrichment of Akkermansia muciniphila (Akk). Microbiota-derived extracellular vesicles (EVs) function as nano-scale mediators that bypass the spatiotemporal constraints of bacterial survival to facilitate long-distance communication with host cells, providing a crucial pathway for downstream mechanistic investigation. Akk-derived EVs (Akk-EVs) are internalized by vascular smooth muscle cells (VSMCs), suppressing osteogenic differentiation and calcification in vitro and in vivo. Proteomic analysis identified B2URF3 as a highly enriched functional protein in Akk-EVs and Akk, which interacts with Aldehyde Dehydrogenase 1 Family Member B1 (ALDH1B1) to inhibit VSMC osteogenic transdifferentiation. Clinically, reduced fecal Akk abundance and lower serum B2URF3 levels were observed in patients with coronary calcification. These findings define a gut-vascular axis by which IF1:1 mitigates VC and nominate Akk-EVs and B2URF3 as potential therapeutic targets and biomarkers.
Insights
Alternate-day intermittent fasting (IF1:1) reduces vascular calcification in mice by enhancing gut bacteria, particularly Akkermansia muciniphila. This effect involves Akk-derived extracellular vesicles carrying the protein B2URF3, offering potential therapeutic targets.
Area of Science:
- Cardiovascular Research
- Microbiome Science
- Metabolic Disease
Background:
- Vascular calcification (VC) significantly increases cardiovascular disease risk, with limited effective treatments.
- The gut microbiome's role in systemic health, including vascular function, is increasingly recognized.
Purpose of the Study:
- To investigate the efficacy of intermittent fasting (IF) regimens in preventing vitamin D-induced VC.
- To elucidate the role of gut microbiota and their derived extracellular vesicles (EVs) in mediating the protective effects of IF against VC.
- To identify specific molecular mechanisms and potential biomarkers involved in the gut-vascular axis.
Main Methods:
- Utilized a mouse model of vitamin D-induced VC to compare alternate-day (IF1:1) and 5:2 IF regimens.
- Assessed the impact of IF on gut microbiota composition, focusing on Akkermansia muciniphila (Akk).
- Investigated the function of Akk-derived EVs (Akk-EVs) in vascular smooth muscle cells (VSMCs) in vitro and in vivo.
- Performed proteomic analysis to identify key proteins within Akk-EVs and Akk, and validated interactions with host proteins.
- Analyzed fecal and serum samples from patients with coronary calcification to correlate findings with clinical observations.
Main Results:
- Alternate-day intermittent fasting (IF1:1) significantly attenuated vitamin D-induced VC in mice, while a 5:2 IF regimen was ineffective.
- The protective effect of IF1:1 was dependent on gut microbiota, specifically an enrichment of Akkermansia muciniphila (Akk).
- Akk-EVs were internalized by VSMCs, suppressing osteogenic differentiation and calcification.
- The protein B2URF3, highly abundant in Akk-EVs and Akk, was identified as a key mediator, interacting with ALDH1B1 to inhibit VSMC osteogenic transdifferentiation.
- Reduced fecal Akk abundance and lower serum B2URF3 levels were observed in patients with coronary calcification.
Conclusions:
- Alternate-day intermittent fasting establishes a gut-vascular axis that mitigates vascular calcification.
- Akkermansia muciniphila and its derived extracellular vesicles (Akk-EVs) play a crucial role in this protective mechanism.
- The Akk-EV protein B2URF3 is a critical mediator inhibiting VSMC osteogenic differentiation and represents a potential therapeutic target and biomarker for vascular calcification.
Related Concept Videos
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Microbiota Modulation by Antibiotics
Inflammatory Bowel Disease II: Ulcerative Colitis

